Pediatric cancer
Conditions
Brief summary
Difference in VZ IgG antibody levels before and after revaccination against chickenpox, Difference in measles IgG antibody level before and after revaccination against measles
Detailed description
Percentage of patients with immunity against chickenpox and measles before and after treatment measured in IgG, Changes in cellmediated immunity (CMI) against chickenpox and measles before and after revaccination. Comparisons with a healthy control group., Differences in antibody levels and CMI between various diagnostic groups (leukemias, solid tumors), different age groups, low- vs. high-intensity treatment, and pre-immune versus non-immune groups
Interventions
Sponsors
Vaestra Goetalandsregionen
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in VZ IgG antibody levels before and after revaccination against chickenpox, Difference in measles IgG antibody level before and after revaccination against measles | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients with immunity against chickenpox and measles before and after treatment measured in IgG, Changes in cellmediated immunity (CMI) against chickenpox and measles before and after revaccination. Comparisons with a healthy control group., Differences in antibody levels and CMI between various diagnostic groups (leukemias, solid tumors), different age groups, low- vs. high-intensity treatment, and pre-immune versus non-immune groups | — |
Countries
Sweden
Outcome results
None listed